BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34374300)

  • 1. NAD
    Chiao YA; Chakraborty AD; Light CM; Tian R; Sadoshima J; Shi X; Gu H; Lee CF
    Circ Heart Fail; 2021 Aug; 14(8):e008170. PubMed ID: 34374300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of NAD+ Redox Balance as a Therapy for Heart Failure.
    Lee CF; Chavez JD; Garcia-Menendez L; Choi Y; Roe ND; Chiao YA; Edgar JS; Goo YA; Goodlett DR; Bruce JE; Tian R
    Circulation; 2016 Sep; 134(12):883-94. PubMed ID: 27489254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both gain and loss of Nampt function promote pressure overload-induced heart failure.
    Byun J; Oka SI; Imai N; Huang CY; Ralda G; Zhai P; Ikeda Y; Ikeda S; Sadoshima J
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H711-H725. PubMed ID: 31347918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
    Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
    Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial NAD
    Berthiaume JM; Kurdys JG; Muntean DM; Rosca MG
    Antioxid Redox Signal; 2019 Jan; 30(3):375-398. PubMed ID: 29073779
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy.
    Tong M; Saito T; Zhai P; Oka SI; Mizushima W; Nakamura M; Ikeda S; Shirakabe A; Sadoshima J
    Circ Res; 2019 Apr; 124(9):1360-1371. PubMed ID: 30786833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective Effects of 1-(3,6-Dibromo-carbazol-9-yl)-3-Phenylamino-Propan-2-Ol in Diabetic Hearts via Nicotinamide Phosphoribosyltransferase Activation.
    Tur J; Badole SL; Manickam R; Chapalamadugu KC; Xuan W; Guida W; Crews JJ; Bisht KS; Tipparaju SM
    J Pharmacol Exp Ther; 2022 Aug; 382(2):233-245. PubMed ID: 35680376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy.
    LaRocca TJ; Altman P; Jarrah AA; Gordon R; Wang E; Hadri L; Burke MW; Haddad GE; Hajjar RJ; Tarzami ST
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice.
    Zhang X; Ke PX; Yuan X; Zhang GP; Chen WL; Zhang GS
    Biomed Res Int; 2021; 2021():8881843. PubMed ID: 33564685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox imbalance and mitochondrial abnormalities in the diabetic lung.
    Wu J; Jin Z; Yan LJ
    Redox Biol; 2017 Apr; 11():51-59. PubMed ID: 27888691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
    Lei L; Hu H; Lei Y; Feng J
    Biochem Biophys Res Commun; 2018 Nov; 506(3):668-673. PubMed ID: 30454704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
    Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y
    Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative effects of chickpea flavonoids on redox imbalance and mitochondrial complex I dysfunction in type 2 diabetic rats.
    Fu Y; Li Z; Xiao S; Zhao C; Zhou K; Cao S
    Food Funct; 2022 Aug; 13(17):8967-8976. PubMed ID: 35938733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Analysis of Major Coenzymes of Cellular Redox Reactions and Energy Using ex Vivo (1)H NMR Spectroscopy.
    Nagana Gowda GA; Abell L; Lee CF; Tian R; Raftery D
    Anal Chem; 2016 May; 88(9):4817-24. PubMed ID: 27043450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats.
    Kumar S; Prasad S; Sitasawad SL
    PLoS One; 2013; 8(7):e67009. PubMed ID: 23843977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.
    Karamanlidis G; Lee CF; Garcia-Menendez L; Kolwicz SC; Suthammarak W; Gong G; Sedensky MM; Morgan PG; Wang W; Tian R
    Cell Metab; 2013 Aug; 18(2):239-50. PubMed ID: 23931755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.